SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma AG & Co. KGaA (FWB: 1SXP) is trading at €24.80, about ₹2,701 at today's EUR/INR rate, as of 30 Sep 2026, 11:29 AM ET, up 0.40% today. Indian residents can buy SCHOTT Pharma AG & Co. KGaA from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
€24.75
Today's high
€25.60
52 week low
€12.62
52 week high
€25.20
1SXP opened at €24.80, closed previously at €24.70, and has traded between €12.62 and €25.20 over the past 52 weeks.
About
Globally, SCHOTT Pharma AG & Co. KGaA specializes in the development, manufacturing, and distribution of sophisticated containment and delivery systems specifically designed for injectable pharmaceuticals, catering to the needs of the pharmaceutical and biotechnology sectors. Their comprehensive product portfolio encompasses both polymer and glass options across various crucial categories, including syringes, ampoules, vials, and cartridges. Their extensive range of syringes features specialized solutions such as the syriQ series (including BioPure for biologics and silicone-free variants) crafted from glass, ideal for vaccines and sensitive biologics, alongside the versatile polymer-based SCHOTT TOPPAC line, tailored for applications from cosmetic treatments and deep-cold storage to infusion therapy and delicate drugs. For cartridges, SCHOTT Pharma provides the cartriQ pharmaceutical glass series, designed for peptide, protein, and large-volume injectables, as well as double-chamber options for lyophilized drugs and break-resistant variants, supplemented by their TopLine and StandardLine offerings. Vial solutions include the adaptiQ pharmaceutical glass vial for general injectables, the EVERIC range focused on drug stability (pure, care for pH, strong & smooth for filling lines), SCHOTT Type I plus for specific formulations, and TopLyo to prevent fogging in lyophilized drugs, alongside their TopLine and StandardLine vials. The ampoule selection features easyOPC for convenient opening, Anti-Counterfeiting ampoules for enhanced security, and their dependable StandardLine options. Established in 1884 and based in Mainz, Germany, SCHOTT Pharma AG & Co. KGaA functions as a subsidiary of Schott Glaswerke Beteiligungs- Und Export Gmbh.
Key statistics
Avg. volume
68.24K
Market cap
€3.74B
P/E Ratio
27.25
Price-to-sales ratio
3.67
Enterprise value
€3.24B
Free cash flow yield
1.11%
Debt-to-equity ratio
0.23
Return on equity
16.42%
ROIC
11.57%
Beta
0.99
Dividend yield
0.73%
Last dividend
€0.18
Financial overview
Revenue
€986.21M
Earnings per share
€0.97
Free cash flow
€35.16M
Net profit margin
13.42%
Gross margin
31.19%
EBITDA
€273.06M
Revenue growth
3.04%
Similar securities
This is not an investment recommendation
How to buy SCHOTT Pharma AG & Co. KGaA from India
Indian residents can buy SCHOTT Pharma AG & Co. KGaA shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to EUR.
Search for SCHOTT Pharma AG & Co. KGaA and place an order
Find SCHOTT Pharma AG & Co. KGaA by name or by its ticker, 1SXP, and choose an order type. SCHOTT Pharma AG & Co. KGaA trades 11:30 am – 11:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your SCHOTT Pharma AG & Co. KGaA position in EUR and INR, and use Paasa's capital-gains and dividend statements when you file your Indian return.
Read the full guide: how to invest in SCHOTT Pharma AG & Co. KGaA from India
Trading and taxes when buying SCHOTT Pharma AG & Co. KGaA from India
Trading and limits
- Trading hours
- 8:00 am – 8:00 pm CET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- Slab rateDividends are taxed at your slab rate in India. SCHOTT Pharma AG & Co. KGaA’s current yield is 0.73%.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy SCHOTT Pharma AG & Co. KGaA stock?
Yes. SCHOTT Pharma AG & Co. KGaA (1SXP) has been listed on the Frankfurt Stock Exchange since 2023, in the Medical - Instruments & Supplies industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to EUR. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one SCHOTT Pharma AG & Co. KGaA share cost in rupees?
One SCHOTT Pharma AG & Co. KGaA share is €24.80 — about ₹2,701 at an EUR/INR rate of 108.91 on 29 Sep 2026. Both the SCHOTT Pharma AG & Co. KGaA price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying SCHOTT Pharma AG & Co. KGaA from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on SCHOTT Pharma AG & Co. KGaA shares taxed in India?
Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the EUR/INR rate on the purchase and the sale date, so the rupee move counts alongside the SCHOTT Pharma AG & Co. KGaA price. Paasa issues a capital-gains statement for your return.
Does SCHOTT Pharma AG & Co. KGaA pay a dividend, and how is it taxed in India?
Yes. SCHOTT Pharma AG & Co. KGaA pays a dividend and the current yield is 0.73%; the last declared dividend was €0.18 per share, about ₹19.60. Dividends are taxed at your slab rate in India. Paasa's dividend report lists the gross dividend and any tax withheld for each payment.
When can I trade SCHOTT Pharma AG & Co. KGaA from India?
The Frankfurt Stock Exchange trades 11:30 am – 11:30 pm IST in Indian time. The window shifts to 12:30 pm – 12:30 am IST when Germany is on standard time. Orders can only execute during that window.
Do I have to declare SCHOTT Pharma AG & Co. KGaA shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your SCHOTT Pharma AG & Co. KGaA holding, its cost and its closing value.
How do I sell SCHOTT Pharma AG & Co. KGaA and bring the money back to India?
You sell during market hours (11:30 am – 11:30 pm IST) and the proceeds settle in EUR in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.
Does the rupee rate affect what I make on SCHOTT Pharma AG & Co. KGaA?
Yes. SCHOTT Pharma AG & Co. KGaA is priced in EUR, so your rupee outcome combines the EUR move with the EUR/INR move between the day you remit and the day you convert back. Both directions are reflected in the capital-gains statement Paasa issues.